Skip to main content
. 2009 Apr 16;2(1):2–6.

Table 4. Availability of information related to clinical use of the medicine in the promotional materials

Criteria Present %(n)
Approved therapeutic use 87.88 (n=29)
Side effects and major ADRs 33.33 (n=11)
Precautions, Contra‐indications, Warnings 36.36 (n=12)
Major interactions 9.09 (n=3)
Management in case of over dose/toxicity 12.12 (n=4)
Use in pregnancy and lactation 12.12 (n=4)